<DOC>
	<DOCNO>NCT00084409</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . Iloprost may effective prevent lung cancer . PURPOSE : This randomized phase II trial study well iloprost work prevent lung cancer patient high risk disease .</brief_summary>
	<brief_title>Iloprost Preventing Lung Cancer Patients High Risk This Disease</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare reversal premalignant histological change bronchial epithelium patient high risk lung cancer ( define &gt; 20 pack year smoke sputum atypia ) treat iloprost v placebo . - Determine whether drug modulates Ki-67 proliferation index patient . - Determine whether drug affect prostaglandin metabolism patient . - Determine toxicity profile drug patient . Secondary - Determine whether drug modulates panel biomarkers , include MCM-2 ( Minichromosome maintenance protein : form DNA helicase ) , EGFR ( Epidermal growth factor receptor : cell surface receptor epidermal growth factor family protein . Mutations EGFR expression activity result cancer . ) , HER2/neu ( Human epidermal growth factor receptor 2 HER2 member EGFR family ) , RARβ ( Retinoic Acic Receptor Beta nuclear transcription regulator member thyroid-steroid hormone receptor superfamily ) , p53 , FHIT ( Fragile histidine triad protein enzyme involve purine metabolism demonstrate tumor suppressor ) , apoptotic index , microvessel density , patient . - Determine gene whose expression alter drug patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord smoking status ( current v former ) participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral iloprost twice daily . - Arm II : Patients receive oral placebo twice daily . In arm , treatment continue 6 month absence unacceptable toxicity . Patients follow 1 month annually thereafter . PROJECTED ACCRUAL : A total 152 patient ( 76 [ 38 current smoker 38 former smoker ] per treatment arm ) accrue study within 2 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Current former* smoker ≥ 20 packyear history smoke NOTE : *Defined tobacco use within past 6 month Mild atypia bad sputum cytology OR bronchial biopsy mild bad dysplasia within past 12 month PATIENT CHARACTERISTICS : Age 18 Performance status SWOG ( Southwest Oncology Group ) 02 Life expectancy At least 6 month Hematopoietic Granulocyte count &gt; 1,500/mm^3 Platelet count &gt; 100,000/mm^3 No clinically apparent bleed diathesis Hepatic Alkaline phosphatase ≤ 2.5 time upper limit normal ( ULN ) Transaminases ≤ 2.5 time ULN Bilirubin ≤ 2.0 mg/dL Albumin ≥ 2.5 g/dL Renal Creatinine ≤ 1.5 mg/dL Cardiovascular No clinically active coronary artery disease No myocardial infarction within past 6 week No chest pain No congestive heart failure No cardiac dysrhythmia potentially lifethreatening Wellcontrolled atrial fibrillation OR rare ( &lt; 2 minute ) premature ventricular contraction allow No ventricular tachycardia No multifocal premature ventricular contraction supraventricular tachycardia rapid ventricular response Pulmonary No pneumonia acute bronchitis within past 2 week No hypoxemia ( &lt; 90 % saturation supplemental oxygen ) Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able willing undergo bronchoscopy No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix No serious medical condition would preclude bronchoscopy study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy More 5 year since prior chemotherapy Endocrine therapy More 6 week since prior inhale steroid Radiotherapy More 5 year since prior thoracic radiotherapy Surgery Not specify Other No prior prostacyclin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>squamous lung dysplasia</keyword>
</DOC>